BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

7 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of novel natural-product-derived mutant isocitrate dehydrogenases 1 inhibitors: Structure-based virtual screening, biological evaluation and structure-activity relationship study.EBI
Chongqing Medical University
Design, Synthesis, and Evaluation of EBI
Chongqing Medical University
Development of [EBI
Chongqing Medical University
Discovery of 2,4-pyrimidinediamine derivatives as potent dual inhibitors of ALK and HDAC.EBI
Chongqing Medical University
Tetrazanbigen Derivatives as Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Partial Agonists: Design, Synthesis, Structure-Activity Relationship, and Anticancer Activities.EBI
Chongqing Medical University
Discovery of novel 9H-purin derivatives as dual inhibitors of HDAC1 and CDK2.EBI
Chongqing Medical University
Novel benzodiazepines derivatives as analgesic modulating for Transient receptor potential vanilloid 1.EBI
Chongqing Medical University